What is the age of Dabur?
Dabur India Limited boasts a rich corporate history spanning over a century and a half, having been originally established in the year 1884 by Dr. S.K. Burman in the-then Calcutta. Starting as a small, pioneering Ayurvedic medicine enterprise operating out of a modest pharmacy, the company has grown into one of the largest multinational consumer goods and natural healthcare corporations in the world, marking well over 140 years of continuous commercial operations, brand development, and herbal product manufacturing across global markets.
Related FAQs
Dabur is widely recognized as one of the world's leaders in Ayurveda and natural healthcare products, offering a portfolio of over 250 herbal and natural consumer goods.
The long-term outlook for Dabur India suggests potential growth, with analysts projecting a target of Rs 591.8 by fiscal year 2028, contingent on sustained earnings growth and potential sector multiple re-ratings.
Whether Dabur is a good stock to buy depends on your investment horizon and risk tolerance. With a base case target of Rs 486.2 for 2026 and long-term potential reaching Rs 591.
Dabur maintains a documented commitment to ethical conduct through its Code of Conduct, which applies to all directors and employees.
Dabur India Limited consensus stock predictions among fast-moving consumer goods analysts reflect a constructive growth outlook, supported by strong brand equity in Ayurvedic and natural healthcare products, expanding rural and urban retail distribut...
Dabur, a major Indian multinational consumer goods company, has periodically encountered public and regulatory scrutiny regarding product ingredient labeling, quality standards testing for packaged juices and ayurvedic formulations, comparative adver...
Dabur India inaugurated a state-of-the-art fast-moving consumer goods manufacturing facility located in Tindivanam, Tamil Nadu.
Dabur India Ltd. is a renowned multinational consumer goods company specializing in ayurvedic, natural healthcare, and personal care products.
The share price of Dabur India Limited (traded on the National Stock Exchange of India under the ticker DABUR) is approximately 424.20 INR.
Yes, Dabur is a profitable company. For the fourth quarter of the 2025-26 fiscal year, Dabur India reported a consolidated net profit of Rs 362 Crore, which was a 16% increase from Rs 312.7 Crore in the previous year.
The iconic global consumer goods and Ayurveda brand name Dabur has a fascinating linguistic origin rooted in late 19th-century India.
Dabur India Limited is a renowned multinational consumer goods company celebrated for its authentic Ayurvedic and natural healthcare products.
Mohit Malhotra, serving as the Chief Executive Officer of Dabur India, receives an annual remuneration package totaling approximately 15.35 crore Indian rupees.
Dabur products are used for health, personal care, and wellness. The company manufactures a variety of Ayurvedic healthcare products and fast-moving consumer goods (FMCG), including hair care, oral care, and food items.
Dr Lal PathLabs provides diagnostic and healthcare testing services internationally across 23 countries, operating through an extensive network that includes more than 150 partner hospitals and reference laboratories.
Enel's primary regional headquarters in the United States, operating as Enel North America, is located in Andover, Massachusetts.
No, Dabur India is not debt-free. As of March 2026, the company's current portion of total debt was 10.902 billion. While the company has actively managed its liabilities over the past five years—with debt levels fluctuating between a low of 4.
The future outlook for Dabur India share prices is supported by its strong brand equity in the fast-moving consumer goods sector, leadership in Ayurvedic health products, and expansive rural and urban distribution networks.